Personalized mRNA cancer vaccine therapy
Therapy that uses a personalized cancer vaccine based on mRNA vaccine technology
From Wikipedia, the free encyclopedia
Personalized mRNA cancer vaccine therapy is a therapy that uses a personalized cancer vaccine based on mRNA vaccine technology to target existing tumors in patients. As of 2024[update], a number of mRNA cancer vaccines are in clinical trials, of which many are personalized therapies based on engineering mRNA-mediated immune response that targets the patient's particular strain of cancer cells.[1]
Experimental treatments include treatments for pancreatic cancer, head and neck cancers, and melanoma.[2][3][4]
In 2024, the British National Health Service announced that had launched its Cancer Vaccine Launch Pad, a collaboration for trials for the use of personalized mRNA cancer vaccines on its patients.[5]
